PBE icon

Invesco Biotechnology & Genome ETF

89 hedge funds and large institutions have $63M invested in Invesco Biotechnology & Genome ETF in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 27 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

67% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 27

Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.7M
2
$9.23M
3
$5.25M
4
$4.58M
5
$3.96M
6
$3.86M
7
$2.75M
8
$1.69M
9
$1.31M
10
$1.24M
11
$1.18M
12
$1.17M
13
$980K
14
$970K
15
$884K
16
$762K
17
$720K
18
$716K
19
$626K
20
$577K
21
$560K
22
$557K
23
$513K
24
$503K
25
$399K